nach oben

Erschienen in:

01.01.2013 | Case Report

Improvement of atrioventricular conduction following catheter ablation of atrioventricular nodal reentry tachycardia in a patient with a prolonged PR interval

verfasst von: Seigo Yamashita, Teiichi Yamane, Seiichiro Matsuo, Keiichi Ito, Ryohsuke Narui, Mika Hioki, Shin-ichi Tanigawa, Michifumi Tokuda, Keiichi Inada, Taro Date, Ken-ichi Sugimoto, Michihiro Yoshimura

Erschienen in: Heart and Vessels | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

We herein present the case of a 60-year-old male with narrow QRS tachycardia who had a remarkable PR prolongation during sinus rhythm. The tachycardia was diagnosed as a slow–fast atrioventricular nodal reentry tachycardia. Slow pathway ablation was performed after the confirmation of the presence of an antegrade fast pathway. Following the elimination of the slow pathway, the PR and atrio-His intervals became shortened from 470 and 420 to 170 and 120 ms, respectively. Moreover, the improvement of atrioventricular conduction after the slow pathway ablation lasted for at least 34 months.

Sakamoto T, Fujiki A, Nakatani Y, Sakabe M, Mizumaki K, Inoue H (2010) Narrow QRS ventricular tachycardia from the posterior mitral annulus without involvement of the His-Purkinje system in a patient with prior inferior myocardial infarction. Heart Vessels 25:170–173PubMedCrossRef

Hioki M, Matsuo S, Yamane T, Tokutake KI, Ito K, Narui R, Tanigawa SI, Yamashita S, Tokuda M, Inada K, Date T, Yoshimura M (2011) Adenosine-induced atrial tachycardia and multiple foci initiating atrial fibrillation eliminated by catheter ablation using a non-contact mapping system. Heart Vessels. doi:10.1007/s00380-011-0159-8

Jackman WM, Beckman KJ, McClelland JH, Wang X, Friday KJ, Roman CA, Moulton KP, Twidale N, Hazlitt HA, Prior MI (1992) Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 327:313–318PubMedCrossRef

Haissaguerre M, Gaita F, Fischer B, Commenges D, Montserrat P, d’Ivernois C, Lemetayer P, Warin JF (1992) Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation 85:2162–2175PubMedCrossRef

Jazayeri MR, Hempe SL, Sra JS, Dhala AA, Blanck Z, Deshpande SS, Avitall B, Krum DP, Gilbert CJ, Akhtar M (1992) Selective transcatheter ablation of the fast and slow pathways using radiofrequency energy in patients with atrioventricular nodal reentrant tachycardia. Circulation 85:1318–1328PubMedCrossRef

Kay GN, Epstein AE, Dailey SM, Plumb VJ (1992) Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Evidence for involvement of perinodal myocardium within the reentrant circuit. Circulation 85:1675–1688PubMedCrossRef

Ridgen LB, Kein LS, Mitrani RD, Zipes DP, Miles WM (1995) Increased risk of heart block following with marked PR interval prolongation during sinus rhythm. Pacing Clin Electrophysiol 18:II-918 (abstract)

Li YG, Grönefeld G, Bender B, Machura C, Hohnloser SH (2001) Risk of development of delayed atrioventricular block after slow pathway modification in patients with atrioventricular nodal reentrant tachycardia and a pre-existing prolonged PR interval. Eur Heart J 22:89–95PubMedCrossRef

Reithmann C, Remp T, Oversohl N, Steinbeck G (2006) Ablation for atrioventricular nodal reentrant tachycardia with a prolonged PR interval during sinus rhythm: the risk of delayed higher-degree atrioventricular block. J Cardiovasc Electrophysiol 17:973–979PubMedCrossRef

10.

Tokuda M, Yamane T, Matsuo S, Ito K, Narui R, Hioki M, Tanigawa SI, Nakane T, Yamashita S, Inada K, Shibayama K, Miyanaga S, Yoshida H, Miyazaki H, Date T, Sugimoto KI, Yoshimura M. (2011) Different strategies for performing pulmonary vein isolation in patients with pulmonary vein rhythm. Heart Vessels. doi:10.1007/s00380-010-0113-1

11.

Knight BP, Zivin A, Souza J, Flemming M, Pelosi F, Goyal R, Man C, Strickberger SA, Morady F (1999) A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory. J Am Coll Cardiol 33:775–781PubMedCrossRef

12.

Miller JM, Rosenthal ME, Gottlieb CD, Vassallo JA, Josephson ME (1991) Usefulness of the delta HA interval to accurately distinguish atrioventricular nodal reentry from orthodromic septal bypass tract tachycardias. Am J Cardiol 68:1037–1044PubMedCrossRef

13.

Tai CT, Chen SA, Chiang CE, Chang MS (1999) Characteristics and radiofrequency catheter ablation of septal accessory atrioventricular pathways. Pacing Clin Electrophysiol 22:500–511PubMedCrossRef

14.

Natale A, Greenfield RA, Geiger MJ, Newby KH, Kent V, Wharton JM, Kearney MM, Brandon MJ, Zimerman L (1997) Safety of slow pathway ablation in patients with long PR interval: further evidence of fast and slow pathway interaction. Pacing Clin Electrophysiol 20:1698–1703PubMedCrossRef

15.

Liu Y, Zeng W, Delmar M, Jalife J (1993) Ionic mechanisms of electronic inhibition and concealed conduction in rabbit atrioventricular nodal myocytes. Circulation 88:1634–1646PubMedCrossRef

16.

Soejima K, Akaishi M, Mitamura H, Ogawa S, Sakurada H, Okazaki H, Motomiya T, Hiraoka M (1997) Increase in heart rate after radiofrequency catheter ablation is mediated by parasympathetic nervous withdrawal and related to site of ablation. J Electrocardiol 30:239–246PubMedCrossRef

17.

Kocovic DZ, Harada T, Shea JB, Soroff D, Friedman PL (1993) Alterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia. Delineation of parasympathetic pathways in the human heart. Circulation 88:1671–1681PubMedCrossRef

18.

Sunagawa K, Kawada T, Nakahara T (1998) Dynamic nonlinear vago-sympathetic interaction in regulating heart rate. Heart Vessels 13:157–174PubMedCrossRef

19.

Sra JS, Jazayeri MR, Blanck Z, Deshpande S, Dhala AA, Akhtar M (1994) Slow pathway ablation in patients with atrioventricular node reentrant tachycardia and a prolonged PR interval. J Am Coll Cardiol 24:1064–1068PubMedCrossRef

20.

Pasquié JL, Scalzi J, Macia JC, Leclercq F, Grolleau-Raoux R (2006) Long-term safety and efficacy of slow pathway ablation in patients with atrioventricular nodal re-entrant tachycardia and pre-existing prolonged PR interval. Europace 8:129–133PubMedCrossRef

Titel: Improvement of atrioventricular conduction following catheter ablation of atrioventricular nodal reentry tachycardia in a patient with a prolonged PR interval
verfasst von: Seigo Yamashita
Teiichi Yamane
Seiichiro Matsuo
Keiichi Ito
Ryohsuke Narui
Mika Hioki
Shin-ichi Tanigawa
Michifumi Tokuda
Keiichi Inada
Taro Date
Ken-ichi Sugimoto
Michihiro Yoshimura
Publikationsdatum: 01.01.2013
Verlag: Springer Japan
Erschienen in: Heart and Vessels / Ausgabe 1/2013
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-012-0234-9

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Hsp90 and its co-chaperone, Sgt1, as autoantigens in dilated cardiomyopathy

Physical activity, adiponectin, and cardiovascular structure and function

Clinical characteristics of silent myocardial ischemia diagnosed with adenosine stress 99mTc-tetrofosmin myocardial scintigraphy in Japanese patients with acute cerebral infarction

The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus

A left ventricular noncompaction in a patient with long QT syndrome caused by a KCNQ1 mutation: a case report